CS274578B2 - Method of substituted 5-halogenthienoisothiazole-3 (2h)-on-1,1-dioxides production - Google Patents

Method of substituted 5-halogenthienoisothiazole-3 (2h)-on-1,1-dioxides production

Info

Publication number
CS274578B2
CS274578B2 CS93189A CS93189A CS274578B2 CS 274578 B2 CS274578 B2 CS 274578B2 CS 93189 A CS93189 A CS 93189A CS 93189 A CS93189 A CS 93189A CS 274578 B2 CS274578 B2 CS 274578B2
Authority
CS
Czechoslovakia
Prior art keywords
dioxides
substituted
halogenthienoisothiazole
production
halogen
Prior art date
Application number
CS93189A
Other languages
English (en)
Other versions
CS93189A2 (en
Inventor
Dieter Dr Binder
Franz Dipl Ing Dr Rovenszky
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of CS93189A2 publication Critical patent/CS93189A2/cs
Publication of CS274578B2 publication Critical patent/CS274578B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS93189A 1988-02-18 1989-02-13 Method of substituted 5-halogenthienoisothiazole-3 (2h)-on-1,1-dioxides production CS274578B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT88390A ATA39088A (de) 1988-02-18 1988-02-18 Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
CS93189A2 CS93189A2 (en) 1990-10-12
CS274578B2 true CS274578B2 (en) 1991-08-13

Family

ID=3489327

Family Applications (1)

Application Number Title Priority Date Filing Date
CS93189A CS274578B2 (en) 1988-02-18 1989-02-13 Method of substituted 5-halogenthienoisothiazole-3 (2h)-on-1,1-dioxides production

Country Status (28)

Country Link
US (1) US4929616A (cs)
EP (1) EP0328913B1 (cs)
JP (1) JPH01249779A (cs)
KR (1) KR890013033A (cs)
CN (1) CN1024798C (cs)
AT (2) ATA39088A (cs)
AU (1) AU618577B2 (cs)
CA (1) CA1317956C (cs)
CS (1) CS274578B2 (cs)
DD (1) DD279021A5 (cs)
DE (1) DE58907804D1 (cs)
DK (1) DK170047B1 (cs)
EG (1) EG20261A (cs)
ES (1) ES2054887T3 (cs)
FI (1) FI89491C (cs)
HR (1) HRP940825A2 (cs)
HU (1) HU201084B (cs)
IL (1) IL89185A (cs)
LT (1) LT3947B (cs)
MY (1) MY103825A (cs)
NO (1) NO176050C (cs)
NZ (1) NZ227939A (cs)
PH (1) PH26156A (cs)
SI (1) SI8910358A (cs)
SU (1) SU1729293A3 (cs)
UA (1) UA13481A (cs)
YU (1) YU35889A (cs)
ZA (1) ZA891108B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071845A (en) * 1988-12-28 1991-12-10 Suntory Limited Benzoxazepine derivative
US8367038B2 (en) 2004-05-23 2013-02-05 HMI Medical Innovations, LLC Therameutin modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CA2631182C (en) * 2005-11-23 2019-08-06 Gerard M. Housey Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用
US8551560B2 (en) * 2008-05-23 2013-10-08 Intermolecular, Inc. Methods for improving selectivity of electroless deposition processes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47877A (en) 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
DE2534689B2 (de) 1974-09-16 1979-03-01 Basf Ag, 6700 Ludwigshafen 23-Dihydro-3-oxo-thieno-isothiazol-1,1-dioxide
LU78009A1 (de) 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
AT364852B (de) * 1977-11-05 1981-11-25 Thomae Gmbh Dr K Verfahren zur herstellung von kondensierten isothiazol-3(2h)-on-1,1-dioxiden und von deren salzen
DE2749640A1 (de) 1977-11-05 1979-05-10 Thomae Gmbh Dr K Ein thieno eckige klammer auf 3,2-d eckige klammer zu isothiazolondioxid, verfahren zu seiner herstellung und dessen verwendung
DE2839266A1 (de) 1978-09-09 1980-03-20 Thomae Gmbh Dr K Kondensierte isothiazol-3(2h)-on-1,1- dioxide, verfahren zu deren herstellung und deren verwendung
DE3371082D1 (de) 1982-09-09 1987-05-27 Hoffmann La Roche Thieno(2,3-e)-1,2-thiazine derivatives
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FI862513A (fi) * 1985-07-04 1987-01-05 Chemie Linz Ag Nya tieno-1,2-tiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity

Also Published As

Publication number Publication date
EP0328913A2 (de) 1989-08-23
LT3947B (en) 1996-05-27
DK73289D0 (da) 1989-02-17
UA13481A (uk) 1997-04-25
NO176050B (no) 1994-10-17
CA1317956C (en) 1993-05-18
SI8910358A (sl) 1997-02-28
JPH01249779A (ja) 1989-10-05
IL89185A0 (en) 1989-09-10
DD279021A5 (de) 1990-05-23
US4929616A (en) 1990-05-29
MY103825A (en) 1993-09-30
NZ227939A (en) 1991-02-26
FI890690A (fi) 1989-08-19
AU618577B2 (en) 1992-01-02
HRP940825A2 (en) 1996-04-30
LTIP1813A (en) 1995-08-25
HUT50839A (en) 1990-03-28
EP0328913A3 (de) 1991-01-23
DK170047B1 (da) 1995-05-08
PH26156A (en) 1992-03-18
KR890013033A (ko) 1989-09-21
CN1038646A (zh) 1990-01-10
NO890691L (no) 1989-08-21
DK73289A (da) 1989-10-11
ZA891108B (en) 1989-10-25
NO890691D0 (no) 1989-02-17
ES2054887T3 (es) 1994-08-16
CN1024798C (zh) 1994-06-01
NO176050C (no) 1995-01-25
YU35889A (en) 1990-06-30
CS93189A2 (en) 1990-10-12
HU201084B (en) 1990-09-28
SU1729293A3 (ru) 1992-04-23
AU2994589A (en) 1989-08-24
EG20261A (en) 1998-05-31
ATA39088A (de) 1990-06-15
FI890690A0 (fi) 1989-02-14
DE58907804D1 (de) 1994-07-14
EP0328913B1 (de) 1994-06-08
FI89491C (fi) 1993-10-11
IL89185A (en) 1992-08-18
ATE106888T1 (de) 1994-06-15
FI89491B (fi) 1993-06-30

Similar Documents

Publication Publication Date Title
MX9701292A (es) Compuestos espiro-azabiciclicos utiles en la terapia.
ZA881726B (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6-carbozamides
CS93189A2 (en) Method of substituted 5-halogenthienoisothiazole-3 (2h)-on-1,1-dioxides production
CS649787A2 (en) Method of new 4,5-dihydrooxazole derivatives production
DE3676378D1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
DE3372970D1 (en) 6-alpha-methyl-prednisolone derivatives, their preparation and utilization
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them